Hangzhou Diagens Biotechnology Co., Ltd.
Status: Publicly traded
Direct answer
Hangzhou Diagens Biotechnology Co., Ltd. is publicly traded on HKSE under the ticker 2526.HK.
Hangzhou Diagens Biotechnology Co., Ltd., a medical devices company, develops medical imaging products and services. It operates through Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others segments. The company's products portfolio include AI AutoVision, a chromosome karyotype assisted diagnosis and analysis system that provides intelligent karyotyping...
Can you invest in Hangzhou Diagens Biotechnology Co., Ltd.?
Yes. Hangzhou Diagens Biotechnology Co., Ltd. trades publicly on HKSE as 2526.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hangzhou Diagens Biotechnology Co., Ltd.
Detailed equity research is provided by MarketSnap.